Fig. 2From: Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysisRisk-of-bias assessment of included RCTs using the revised Cochrane risk-of-bias tool for randomized trials (RoB 2.0) (A) and of one cohort study using Risk of Bias In Non-randomized Studies of Interventions (ROBINS-I tool) (B)Back to article page